MENU CARDEA 20/20 ECG Built on Experience, Expertise and Research Sudden Cardiac Arrest is the number one medical cause of death in athletes during sports. Yet current ECG algorithms are not tuned to the normal range of conditions present in athletes, resulting in high false-positive findings and unnecessary medical expenses associated with follow-up diagnostic tests. Cardea 20/20 ECG™ is the only reliable, automated diagnostic system designed to identify cardiac conditions associated with sudden cardiac death in active youth and athletes. Identifying cardiac conditions associated with sudden cardiac death is an important component to pre-participation sports exams (PPE), athlete sports physicals and cardiac screening programs as well as routine physicals. • ~2% false positives: the industry’s lowest compared to an historical false-positive rate of up to 30% in other devices • Breakthrough Interpretation: only system automated with International Criteria • Better Analysis: high ECG sample rate, industry-leading signal resolution and extended recording time ensure accuracy • Reduced Costs: low false positives limits unnecessary follow-up testing • Portable: lightweight ECG transmitter connects via USB cable to standard Windows® PC and can easily be transported to multiple locations • Collaborative: robust ECG editing and analysis tools for physician over-reads • Cloud-Based Storage Supported: save and share data Who It’s For How It Works Product Specs Resources Cardea 20/20 ECG Information Complete this form to receive information for Cardea 20/20 ECG. Full Name* First Last Email* Phone* Practice/Foundation/Company* “The cardiovascular program at St. Joe’s feels very strongly that we have an obligation to our community to screen for teens at risk for sudden cardiac arrest. We’ve yet to have a screening where a significant risk factor was not identified. The key to the Cardea 20/20 ECG platform is its proprietary algorithm that specifically looks for difficult-to-diagnose heart conditions. Given there’s a real lack of education about the incidence of SCA in youth and how to catch it, our goal is to drive a standard of care that ultimately will be adopted by primary care physicians. With more youth at risk in this young generation, it’s better health care to manage a condition now than to wait for it to become a major catastrophe in their 30s.” Jerry Marschke, Executive Director Cardiovascular Services – PeaceHealth HOME ABOUT About Our Team News Events Blog Innovation with Impact PATIENTS CUSTOMERS Cardea SOLO Research VA / DOD PRODUCTS Cardea SOLO™ ECG System Cardea SOLO Reimbursement Cardea 20/20 ECG CONTACT US © 2021 Cardiac Insight Inc. All rights reserved. Privacy Policy Support by Seattle Web Design